| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |